|
1
|
Kanthan R, Senger JL, Ahmed S and Kanthan
SC: Gallbladder Cancer in the 21st Century. J Oncol.
2015:9674722015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiahong D, Jianming W and Jianping Z:
Guidelines for diagnosis and treatment of gallbladder cancer (2015
edition). J Clin Hepatol. 32:411–419. 2015.
|
|
3
|
Kakaei F, Beheshtirouy S, Nejatollahi SM,
Zarrintan S and Mafi MR: Surgical treatment of gallbladder
carcinoma: A critical review. Updates Surg. 67:339–351. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cziupka K, Partecke LI, Mirow L, Heidecke
CD, Emde C, Hoffmann W, Siewert U, van den Berg N, von Bernstorff W
and Stier A: Outcomes and prognostic factors in gallbladder cancer:
A single-centre experience. Langenbecks Arch Surg. 397:899–907.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lazcano-Ponce EC, Miquel JF, Muñoz N,
Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista
G and Nervi F: Epidemiology and molecular pathology of gallbladder
cancer. CA Cancer J Clin. 51:349–364. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mekeel KL and Hemming AW: Surgical
management of gallbladder carcinoma: A review. J Gastrointest Surg.
11:1188–1193. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang LF, Hou CS, Xu Z, Guo LM, Ling XF,
Wang LX and Xiu DR: Laparoscopic treatment for incidental
gallbladder cancer: A retrospective 10 years study from a single
institution. Zhonghua Wai Ke Za Zhi. 57:277–281. 2019.(In Chinese).
PubMed/NCBI
|
|
8
|
Butte JM, Matsuo K, Gönen M, D'Angelica
MI, Waugh E, Allen PJ, Fong Y, DeMatteo RP, Blumgart L, Endo I, et
al: Gallbladder cancer: Differences in presentation, surgical
treatment, and survival in patients treated at centers in three
countries. J Am Coll Surg. 212:50–61. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu J: PUMA kills stem cells to stall
cancer? Mol Cell Pharmacol. 1:112–118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu J, Wang Z, Kinzler KW, Vogelstein B and
Zhang L: PUMA mediates the apoptotic response to p53 in colorectal
cancer cells. Proc Natl Acad Sci USA. 100:1931–1936. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He S, Ma X, Ye Y, Zhang M, Zhuang J, Song
Y and Xia W: HEATR1 modulates cell survival in non-small cell lung
cancer via activation of the p53/PUMA signaling pathway. Onco
Targets Ther. 12:4001–4011. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yee KS, Wilkinson S, James J, Ryan KM and
Vousden KH: PUMA- and Bax-induced autophagy contributes to
apoptosis. Cell Death Differ. 16:1135–1145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sinicrope FA, Rego RL, Okumura K, Foster
NR, O'Connell MJ, Sargent DJ and Windschitl HE: Prognostic impact
of bim, puma, and noxa expression in human colon carcinomas. Clin
Cancer Res. 14:5810–5818. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Diallo JS, Aldejmah A, Mouhim AF, Péant B,
Fahmy MA, Koumakpayi IH, Sircar K, Bégin LR, Mes-Masson AM and Saad
F: NOXA and PUMA expression add to clinical markers in predicting
biochemical recurrence of prostate cancer patients in a survival
tree model. Clin Cancer Res. 13:7044–7052. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nevin JE, Moran TJ, Kay S and King R:
Carcinoma of the gallbladder: Staging, treatment, and prognosis.
Cancer. 37:141–148. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sharma A, Kumar A, Kumari N, Krishnani N
and Rastogi N: Mutational frequency of KRAS, NRAS, IDH2, PIK3CA,
and EGFR in North Indian gallbladder cancer patients.
Ecancermedicalscience. 11:7572017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim YW, Huh SH, Park YK, Yoon TY, Lee SM
and Hong SM: Expression of the c-erb-B2 and p53 protein in
gallbladder carcinomas. Oncol Rep. 8:1127–1132. 2001.PubMed/NCBI
|
|
19
|
Niizuma K, Endo H, Nito C, Myer DJ and
Chan PH: Potential role of PUMA in delayed death of hippocampal CA1
neurons after transient global cerebral ischemia. Stroke.
40:618–625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun YL, Jiang WQ, Luo QY, Yang DJ, Cai YC,
Huang HQ and Sun J: A novel Bcl-2 inhibitor, BM-1197, induces
apoptosis in malignant lymphoma cells through the endogenous
apoptotic pathway. BMC Cancer. 20:12019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Letai A: Puma strikes Bax. J Cell Biol.
185:189–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Erlacher M, Labi V, Manzl C, Böck G,
Tzankov A, Häcker G, Michalak E, Strasser A and Villunger A: Puma
cooperates with Bim, the rate-limiting BH3-only protein in cell
death during lymphocyte development, in apoptosis induction. J Exp
Med. 203:2939–2951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai W, Li Q, Yang Z, Miao X, Wen Y, Huang
S and Ouyang J: Expression of p53 upregulated modulator of
apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their
pathological significance. Clin Transl Oncol. 15:818–824. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shu GS, Lv F, Yang ZL and Miao XY:
Immunohistochemical study of PUMA, c-Myb and p53 expression in the
benign and malignant lesions of gallbladder and their
clinicopathological significances. Int J Clin Oncol. 18:641–650.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei D, Zhang X, Zou H, Wang L, Fu B, Wu X,
Luo Z, Li X, Ge J, Li Y, et al: WW domain containing oxidoreductase
induces apoptosis in gallbladder-derived malignant cell by
upregulating expression of P73 and PUMA. Tumour Biol. 35:1539–1550.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and desease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu XT, Dai Z, Song K, Zhang ZJ, Zhou ZJ,
Zhou SL, Zhao YM, Xiao YS, Sun QM, Ding ZB and Fan J:
Macrophage-secreted IL-8 induces epithelial-mesenchymal transition
in hepatocellular carcinoma cells by activating the
JAK2/STAT3/Snail pathway. Int J Oncol. 46:587–596. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Babu PP, Suzuki G, Ono Y and Yoshida Y:
Attenuation of ischemia and/or reperfusion injury during myocardial
infarction using mild hypothermia in rats: An immunohistochemical
study of bcl-2, bax, Bak and TUNEL. Pathol Int. 54:896–903. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Duan XX, Ou JS, Li Y, Su JJ, Ou C, Yang C,
Yue HF and Ban KC: Dynamic expression of apoptosis related genes
during development of laboratory hepatocellular carcinoma and its
relation to apoptosis. World J Gastroenterol. 11:4740–4744. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martin LJ: Neuronal cell death in nervous
system development, disease, and injury (Review). Int J Mol Med.
7:455–478. 2001.PubMed/NCBI
|
|
32
|
Cecconi F, Alvarez-Bolado G, Meyer BI,
Roth KA and Gruss P: Apaf1 (CED-4 homolog) regulates programmed
cell death in mammalian development. Cell. 94:727–737. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
McDonnell TJ, Troncoso P, Brisbay SM,
Logothetis C, Chung LW, Hsieh JT, Tu SM and Campbell ML: Expression
of the protooncogene Bcl-2 in the prostate and its association with
emergence of androgen-independent prostate cancer. Cancer Res.
52:6940–6944. 1992.PubMed/NCBI
|
|
34
|
Roos A, Sato T, Maier H, van Kooten C and
Daha MR: Induction of renal cell apoptosis by antibodies and
compiement. Exp Nephrol. 9:65–70. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fan ZC, Yan J, Liu GD, Tan XY, Weng XF, Wu
WZ, Zhou J and Wei XB: Real-time monitoring of rare circulating
hepatocelluar carcinoma cells in an orthotopic model by in vivo
flow cytometry assesses resection on metastasis. Cancer Res.
72:2683–2691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yan J, Fan Z, Wu X, Xu M, Jiang J, Tan C,
Wu W, Wei X and Zhou J: Circulating tumor cells are correlated with
disease progression and treatment response in an orthotopic
hepatocellular carcinoma model. Cytometry A. 87:1020–1028. 2015.
View Article : Google Scholar : PubMed/NCBI
|
